Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-02-23 Sale |
2022-02-24 4:11 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
6,781 | $613.99 | $4,163,489 | 31,626 (Indirect Direct) |
View |
| 2022-02-23 Sale |
2022-02-24 4:07 pm |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
500 | $608.68 | $304,340 | 13,244 (Indirect Direct) |
View |
| 2022-02-15 Sale |
2022-02-16 4:18 pm |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
3,540 | $629.34 | $2,227,851 | 92,739 (Indirect Direct) |
View |
| 2022-02-01 Sale |
2022-02-02 4:16 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $607.14 | $60,714 | 22,482 (Direct) |
View |
| 2022-02-01 Sale |
2022-02-02 4:14 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $607.46 | $607,460 | 27,760 (Indirect Direct) |
View |
| 2022-01-03 Sale |
2022-01-05 4:25 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $625 | $625,000 | 28,760 (Indirect Direct) |
View |
| 2022-01-03 Sale |
2022-01-05 4:22 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $624.95 | $62,495 | 25,289 (Direct) |
View |
| 2021-12-13 Sale |
2021-12-14 4:05 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
344 | $653.12 | $224,673 | 19,760 (Indirect Direct) |
View |
| 2021-12-13 Sale |
2021-12-14 4:03 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
116 | $662.5 | $76,850 | 31,989 (Indirect Direct) |
View |
| 2021-12-10 Sale |
2021-12-10 6:42 pm |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
7,122 | $666.27 | $4,745,202 | 78,219 (Indirect Direct) |
View |
| 2021-12-09 Sale |
2021-12-10 5:41 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director |
3,784 | $665 | $2,516,360 | 2,078 (Direct) |
View |
| 2021-12-10 Sale |
2021-12-10 5:37 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
781 | $666.42 | $520,477 | 64,144 (Indirect Direct) |
View |
| 2021-12-01 Sale |
2021-12-02 4:07 pm |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
100 | $637.53 | $63,753 | 22,491 (Direct) |
View |
| 2021-12-01 Sale |
2021-12-02 4:04 pm |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $639.13 | $639,130 | 27,154 (Indirect Direct) |
View |
| 2021-11-19 Sale |
2021-11-23 4:29 pm |
REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director |
3,000 | $656.67 | $1,970,000 | 32,008 (Indirect Direct) |
View |
| 2021-11-17 Sale |
2021-11-18 4:23 pm |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
681 | $645.08 | $439,299 | 47,465 (Indirect Direct) |
View |
| 2021-11-16 Sale |
2021-11-18 4:09 pm |
REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director |
10,750 | $653.5 | $7,025,080 | 35,008 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-22 Exercise |
2022-02-24 4:11 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
40,000 | $399.66 | 31,626 (Direct) |
View |
| 2022-02-22 Tax Withholding |
2022-02-24 4:11 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
33,219 | $610.56 | 31,626 (Direct) |
View |
| 2022-02-22 Exercise |
2022-02-24 4:11 pm |
N/A 2024-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
40,000 | $0 | 31,626 (Direct) |
View |
| 2022-02-14 Tax Withholding |
2022-02-16 4:18 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
6,460 | $626.79 | 92,739 (Direct) |
View |
| 2022-02-14 Exercise |
2022-02-16 4:18 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
10,000 | $179.13 | 92,739 (Direct) |
View |
| 2022-02-14 Exercise |
2022-02-16 4:18 pm |
N/A 2022-12-14 |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
10,000 | $0 | 92,739 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-02 4:14 pm |
N/A 2028-02-12 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $0 | 27,760 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-02 4:14 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $342.93 | 27,760 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:44 pm |
N/A 2032-01-03 |
REGENERON PHARMACEUTICALS INC. | REGN | POON CHRISTINE A Director |
2,898 | $0 | 4,579 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 4:25 pm |
N/A 2028-02-12 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $0 | 28,760 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 4:25 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $342.93 | 28,760 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:24 pm |
N/A 2032-01-03 |
REGENERON PHARMACEUTICALS INC. | REGN | Zoghbi Huda Y Director |
2,898 | $0 | 3,789 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:23 pm |
N/A 2032-01-03 |
REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director |
2,898 | $0 | 4,976 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:23 pm |
N/A 2032-01-03 |
REGENERON PHARMACEUTICALS INC. | REGN | COLES N ANTHONY Director |
2,898 | $0 | 3,800 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:22 pm |
N/A 2032-01-03 |
REGENERON PHARMACEUTICALS INC. | REGN | Bassler Bonnie L Director |
2,898 | $0 | 3,789 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:22 pm |
N/A 2032-01-03 |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
2,898 | $0 | 25,289 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:21 pm |
N/A 2032-01-03 |
REGENERON PHARMACEUTICALS INC. | REGN | SING GEORGE L Director |
2,898 | $0 | 34,906 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:19 pm |
N/A 2032-01-03 |
REGENERON PHARMACEUTICALS INC. | REGN | GOLDSTEIN JOSEPH L Director |
2,898 | $0 | 8,789 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 4:18 pm |
N/A 2032-01-03 |
REGENERON PHARMACEUTICALS INC. | REGN | BROWN MICHAEL S Director |
2,898 | $0 | 16,451 (Direct) |
View |
| 2021-12-22 Exercise |
2021-12-23 4:29 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | YANCOPOULOS GEORGE President and Chief Scientific |
239,063 | $179.13 | 1,239,194 (Direct) |
View |
| 2021-12-22 Tax Withholding |
2021-12-23 4:29 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | YANCOPOULOS GEORGE President and Chief Scientific |
310,097 | $610.04 | 1,239,194 (Direct) |
View |
| 2021-12-22 Exercise |
2021-12-23 4:29 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | YANCOPOULOS GEORGE President and Chief Scientific |
203,204 | $270.43 | 1,239,194 (Direct) |
View |
| 2021-12-22 Exercise |
2021-12-23 4:29 pm |
N/A 2022-12-14 |
REGENERON PHARMACEUTICALS INC. | REGN | YANCOPOULOS GEORGE President and Chief Scientific |
442,267 | $0 | 1,239,194 (Direct) |
View |
| 2021-12-16 I |
2021-12-20 4:13 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Director |
19 | $634.7 | 503,750 (Indirect) |
View |
| 2021-12-16 I |
2021-12-20 4:13 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Director |
107 | $635.03 | 503,750 (Indirect) |
View |
| 2021-12-11 Tax Withholding |
2021-12-14 4:10 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
270 | $664.34 | 27,958 (Direct) |
View |
| 2021-12-11 Tax Withholding |
2021-12-14 4:09 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
697 | $664.34 | 62,739 (Direct) |
View |
| 2021-12-11 Tax Withholding |
2021-12-14 4:08 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
753 | $664.34 | 63,527 (Direct) |
View |
| 2021-12-11 Tax Withholding |
2021-12-14 4:07 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
697 | $664.34 | 29,551 (Direct) |
View |
| 2021-12-11 Tax Withholding |
2021-12-14 4:05 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
388 | $664.34 | 19,760 (Direct) |
View |
| 2021-12-11 Tax Withholding |
2021-12-14 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
697 | $664.34 | 31,626 (Direct) |
View |
| 2021-12-10 Tax Withholding |
2021-12-14 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
2,081 | $664.34 | 31,989 (Direct) |
View |
| 2021-12-10 Exercise |
2021-12-14 4:03 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
1,500 | $555.67 | 31,989 (Direct) |
View |
| 2021-12-10 Exercise |
2021-12-14 4:03 pm |
N/A 2025-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
1,500 | $0 | 31,989 (Direct) |
View |
| 2021-12-09 Exercise |
2021-12-10 6:42 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
16,500 | $52.03 | 78,219 (Direct) |
View |
| 2021-12-09 Tax Withholding |
2021-12-10 6:42 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
9,378 | $657.11 | 78,219 (Direct) |
View |
| 2021-12-09 Exercise |
2021-12-10 6:42 pm |
N/A 2021-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
16,500 | $0 | 78,219 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 6:42 pm |
N/A 2031-12-08 |
REGENERON PHARMACEUTICALS INC. | REGN | MURPHY ANDREW J EVP Research |
18,245 | $0 | 78,219 (Direct) |
View |
| 2021-12-09 Exercise |
2021-12-10 5:41 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director |
3,784 | $371.4 | 2,078 (Direct) |
View |
| 2021-12-09 Exercise |
2021-12-10 5:41 pm |
N/A 2029-01-02 |
REGENERON PHARMACEUTICALS INC. | REGN | Tessier-Lavigne Marc Director |
3,784 | $0 | 2,078 (Direct) |
View |
| 2021-12-09 Tax Withholding |
2021-12-10 5:37 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
3,469 | $657.11 | 64,144 (Direct) |
View |
| 2021-12-09 Exercise |
2021-12-10 5:37 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
4,250 | $399.66 | 64,144 (Direct) |
View |
| 2021-12-09 Exercise |
2021-12-10 5:37 pm |
N/A 2024-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
4,250 | $0 | 64,144 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 5:37 pm |
N/A 2031-12-08 |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
20,929 | $0 | 64,144 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 5:36 pm |
N/A 2031-12-08 |
REGENERON PHARMACEUTICALS INC. | REGN | Van Plew Daniel P EVP & General Mgr, Industrial |
22,892 | $0 | 50,871 (Direct) |
View |
| 2021-10-04 Gift |
2021-12-10 5:35 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Director |
347 | $0 | 525,074 (Indirect) |
View |
| 2021-12-08 Option Award |
2021-12-10 5:35 pm |
N/A 2031-12-08 |
REGENERON PHARMACEUTICALS INC. | REGN | VAGELOS P ROY Director |
23,059 | $0 | 525,074 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 5:35 pm |
N/A 2031-12-08 |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
15,420 | $0 | 76,774 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 5:31 pm |
N/A 2031-12-08 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
17,591 | $0 | 34,745 (Direct) |
View |
| 2021-12-09 Exercise |
2021-12-10 5:30 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
30,000 | $179.13 | 44,501 (Direct) |
View |
| 2021-12-09 Tax Withholding |
2021-12-10 5:30 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
19,772 | $657.11 | 44,501 (Direct) |
View |
| 2021-12-09 Exercise |
2021-12-10 5:30 pm |
N/A 2022-12-14 |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
30,000 | $0 | 44,501 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 5:30 pm |
N/A 2031-12-08 |
REGENERON PHARMACEUTICALS INC. | REGN | LAROSA JOSEPH J EVP General Counsel and Secret |
17,591 | $0 | 44,501 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 5:28 pm |
N/A 2031-12-08 |
REGENERON PHARMACEUTICALS INC. | REGN | Fenimore Christopher R. SVP Controller |
9,800 | $0 | 36,169 (Direct) |
View |
| 2021-12-03 Exercise |
2021-12-06 4:10 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
72,500 | $179.13 | 61,354 (Direct) |
View |
| 2021-11-29 Gift |
2021-12-06 4:10 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
4,605 | $0 | 61,354 (Direct) |
View |
| 2021-12-03 Tax Withholding |
2021-12-06 4:10 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
50,352 | $632.45 | 61,354 (Direct) |
View |
| 2021-12-03 Exercise |
2021-12-06 4:10 pm |
N/A 2022-12-14 |
REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development |
72,500 | $0 | 61,354 (Direct) |
View |
| 2021-11-16 Gift |
2021-12-02 4:07 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | RYAN ARTHUR F Director |
500 | $0 | 22,491 (Direct) |
View |
| 2021-12-01 Exercise |
2021-12-02 4:04 pm |
N/A 2028-02-12 |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $0 | 27,154 (Direct) |
View |
| 2021-12-01 Exercise |
2021-12-02 4:04 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | McCourt Marion EVP Commercial |
1,000 | $342.93 | 27,154 (Direct) |
View |
| 2021-11-19 Exercise |
2021-11-19 5:50 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | SCHLEIFER LEONARD S President & CEO |
281,250 | $179.13 | 692,974 (Direct) |
View |
| 2021-11-19 Exercise |
2021-11-19 5:50 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | SCHLEIFER LEONARD S President & CEO |
239,063 | $270.43 | 692,974 (Direct) |
View |
| 2021-11-19 Tax Withholding |
2021-11-19 5:50 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | SCHLEIFER LEONARD S President & CEO |
359,137 | $651.96 | 692,974 (Direct) |
View |
| 2021-11-19 Exercise |
2021-11-19 5:50 pm |
N/A 2022-12-14 |
REGENERON PHARMACEUTICALS INC. | REGN | SCHLEIFER LEONARD S President & CEO |
520,313 | $0 | 692,974 (Direct) |
View |
| 2021-11-16 Exercise |
2021-11-18 4:23 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
3,750 | $399.66 | 47,465 (Direct) |
View |
| 2021-11-16 Tax Withholding |
2021-11-18 4:23 pm |
N/A N/A |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
3,069 | $651.97 | 47,465 (Direct) |
View |
| 2021-11-16 Exercise |
2021-11-18 4:23 pm |
N/A 2024-12-16 |
REGENERON PHARMACEUTICALS INC. | REGN | Landry Robert E EVP Finance CFO |
3,750 | $0 | 47,465 (Direct) |
View |